Altria Group, Inc. - Financial and Strategic Analysis Review
Altria Group, Inc. (Altria Group) is one of the global leaders in the tobacco industry. It is engaged in the business line of manufacturing and sale of cigarettes, moist smokeless tobacco, and machine-made large cigars and other tobacco products in the US and various international markets. The key brands offered by the company include Marlboro, Copenhagen, Skoal and Black & Mild. Altria Group holds 100% outstanding stock of Philip Morris USA, Philip Morris Capital Corporation, John Middleton, U.S. Smokeless Tobacco Co., and Ste. Michelle Wine Estates. In addition, the company also holds interest in SABMiller, which is engaged in the manufacture and sale of various beer products.
Global Markets Direct's Altria Group, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Altria Group, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Global Market Direct's Endologix, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Endologix, Inc. (Endologix) develops, manufactures and sells minimally invasive treatments for vascular diseases. The company is focusing on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). AAA is a weakening of the wall of the aorta which is the largest artery of the body. Endologix markets its Powerlink Delivery System an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA that has certain advantages when compared to marketed stent alternatives. The company received FDA approval for the Powerlink AAA stent graft in 2004. The Powerlink superior design is covered by 17 US patents with 361 allowed claims.And More inside the report...
This report covers the following industry codes:
SIC Code: 3841
NAICS Code: 332994
Endologix, Inc. (Endologix) is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its Powerlink Delivery System is an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA; and has certain advantages when compared to marketed stent alternatives. The Powerlink superior design is covered by 17 US issued patents with 361 claims. The device is available in the US and selected international markets. The company is headquartered in California, the US.
Endologix, Inc. Key Recent Developments
Oct 27, 2011: Endologix Reports Revenues Of $22.3m In Q3 2011
Aug 30, 2011: Endologix Appoints Ruth Lyons As Vice President, Global Marketing
Aug 18, 2011: Cook Medical Remains Resolute In Pursuit Of Infringement Action Against Endologix Following Markman Ruling
Aug 17, 2011: Endologix Announces Favorable Markman Ruling In Cook Patent Litigation
Jul 21, 2011: Endologix Reports Total Revenue Of $19.2m In Q2 2011
This comprehensive SWOT profile of Endologix, Inc. provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Note: Some sections may be missing if data is unavailable for the company.
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
Endologix, Inc. (ELGX) - Product Pipeline Analysis
Endologix, Inc. (Endologix) is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its Powerlink Delivery System is an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA; and has certain advantages when compared to marketed stent alternatives. The Powerlink superior design is covered by 17 US issued patents with 361 claims. The device is available in the US and selected international markets. The company is headquartered in California, the US.
This report is a source for data, analysis and actionable intelligence on the Endologix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
This report covers the following industry codes:
SIC Code: 3841
NAICS Code: 332994
Black Box Corporation (Black Box) is a network infrastructure services providing company. It is involved in providing communications and infrastructure solutions. The company is engaged in designing, building, monitoring and maintaining of complex voice and data networks. Black Box focuses on three solution areas communication, infrastructure and provides products to maintain the clients infrastructure. The company's offerings can be categorized under three services namely, Voice Services, Data Services, and Hotline Services. In addition, it also offers technical support and services. The company offers one source network infrastructure services to communication industries. Black Box is headquartered at Lawrence in Pennsylvania, the US.
This comprehensive SWOT profile of Black Box Corporation provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Black Box Corporation including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
Note*: Some sections may be missing if data is unavailable for the company.
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
This report covers the following industry codes:
SIC Code: 4813
NAICS Code: 51334
Avanti Feeds limited (Avanti Feeds) is a provider of feeds and technical services to the Shrimp culture farmers. Furthermore, the company is also engaged in wind power project with a capacity of 3.2 MW. Avanti Feeds has three divisions, namely, Shrimp Feed division, Aqua Products Export division and Shrimp Shell Meal division. The company's Shrimp Feed Division has two feed manufacturing plants, with the capacity of 70,000 MTs per annum feed production. The company's Aqua Products Export division is engaged in to the processing of black tiger, Scampi shrimps through its plant, which has a capacity of 1200 MT. p.a. It exports its products to EU, the US and Japan. Shrimp Shell Meal division has the capacity of 1000 M.Ts per annum. The company is one of the leading manufacturer of Shrimp Feed in India. The company is headquartered at Kovvur in Andhra Pradesh, India.
This comprehensive SWOT profile of Avanti Feeds Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Avanti Feeds Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
Note*: Some sections may be missing if data is unavailable for the company.
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
This report covers the following industry codes:
SIC Code: 5421
NAICS Code: 44522
Trans Hex Group Limited (Trans Hex) is one of the leading diamond mining companies in the world. The company is engaged in the exploration, mining, and marketing of high quality diamonds. It manages land operations at the Baken Central Plant, the Nxodap plant, and Bloeddrif plant, which are situated along the banks of the Orange River in South Africa. It manages exploration and mining operations in Angola through 35% interest in the Luarica project and 32% interest in the Fucauma project. The company also established a small-scale black joint venture polishing factory, Urembo Diamonds (Pty) Limited in Johannesburg. Trans Hex is headquartered in Parow, South Africa.
This comprehensive SWOT profile of Trans Hex Group Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Trans Hex Group Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
Note*: Some sections may be missing if data is unavailable for the company.
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Gain key insights into the company for academic or business research.
This report covers the following industry codes:
SIC Code: 1499
NAICS Code: 212399
Endologix, Inc. (Endologix) is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its Powerlink Delivery System is an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA; and has certain advantages when compared to marketed stent alternatives. The Powerlink superior design is covered by 17 US issued patents with 361 claims. The device is available in the US and selected international markets. The company is headquartered in California, the US.
Endologix, Inc. (ELGX) - Medical Equipment - Deals and Alliances Profile provides you an in-depth data and trend analysis of the company's mergers and acquisitions (M&A) and financings. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered by the company over a five year period. The report portrays detailed comparative data on the number of deals and their value subdivided by deal types, markets, and regions, besides highlighting the company's major recent financial deals.
Data presented in this report was derived from GlobalData's proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements.
Understand the company's business segments' expansion / divesture strategy
Access detailed information about the company's recent financial deals that enables you to understand the key deals which have shaped the company
Equip yourself with detailed information about the company to identify potential customers and suppliers.
Hugo Boss AG (Hugo) is one of the leading companies in the world fashion markets. The company principally engages in the manufacturing of clothes for men and women. It also offers fragrances, cosmetics, watches, and eyewear through licensed agreements. Hugo offers its products under two major brands, namely, HUGO and BOSS. Brands in the menswear collection include the BOSS Black, BOSS Selection, BOSS Orange, and BOSS Green as well as by the HUGO brand. Brands in the women's wear group include BOSS Black, BOSS Orange lines, BOSS Green and the HUGO brand. The company sells its products in Europe, Asia, and American countries through 364 directly operated stores. The company principally categorized its operations into four business segments, namely, Europe, Americas, Asia/Pacific and Licenses. The company is headquartered in Metzingen, Germany.
This comprehensive SWOT profile of Hugo Boss AG provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
You get detailed information about the company and its operations to identify potential customers and suppliers.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.